Baynes Roy D.

Baynes Roy D. serves as a Director at Natera, Inc., where he is involved in overseeing the company's strategic direction in the healthcare sector. His recent disclosures reflect a pattern of sale activity, with a total of six reported transactions between February 2025 and June 2026. Notably, the largest disclosed move was a sale of $1.1 million in Travere Therapeutics, Inc. on April 16, 2026, indicating a significant engagement with the healthcare investment landscape.